| 1 | = | Malignant Nasopharyngeal Neoplasm | 393.1 | 100 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 664
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 261
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9070
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580266 |
| 2 | = | Hodgkin Lymphoma | 196.9 | 97.1 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 909
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 179
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10891
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580267 |
| 3 | = | Malignant Cervical Neoplasm | 120 | 94.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 4207
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 505
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10261
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580268 |
| 4 | = | Non-Hodgkin Lymphoma | 109 | 91.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 19882
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 2168
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10954
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580269 |
| 5 | = | Malignant Hypopharyngeal Neoplasm | 106.4 | 88.2 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 498
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 53
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9133
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580270 |
| 6 | = | Malignant Penile Neoplasm | 103.6 | 85.3 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 415
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 43
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10450
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580271 |
| 7 | = | Malignant Testicular Neoplasm | 93.1 | 82.4 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 462
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 43
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10576
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580272 |
| 8 | = | Malignant Thyroid Gland Neoplasm | 79 | 79.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 2229
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 176
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10828
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580273 |
| 9 | = | Leukemia | 74.5 | 76.5 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 23740
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 1769
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 11080
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580274 |
| 10 | = | Malignant Vaginal Neoplasm | 71.3 | 73.5 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 435
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 31
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10198
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580275 |
| 11 | = | Multiple Myeloma | 68 | 70.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 11967
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 814
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 11017
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580276 |
| 12 | = | Malignant Breast Neoplasm | 59.8 | 67.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 43897
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 2627
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10072
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580277 |
| 13 | = | Malignant Gastric Neoplasm | 58 | 64.7 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 11246
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 652
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9259
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580278 |
| 14 | = | Malignant Ovarian Neoplasm | 54.1 | 61.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 12654
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 684
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10387
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580279 |
| 15 | = | Malignant Salivary Gland Neoplasm | 53.7 | 58.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 1173
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 63
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 8944
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580280 |
| 16 | = | Malignant Uterine Corpus Neoplasm | 47.7 | 55.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 8608
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 411
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10324
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580281 |
| 17 | = | Malignant Mesothelioma | 45.4 | 52.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 2114
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 96
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9952
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580282 |
| 18 | = | Malignant Central Nervous System Neoplasm | 44.4 | 50 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 18523
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 823
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10765
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580283 |
| 19 | = | Malignant Oropharyngeal Neoplasm | 43.5 | 47.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 3286
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 143
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9007
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580284 |
| 20 | = | Malignant Anal Neoplasm | 41.2 | 44.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 1651
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 68
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9448
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580285 |
| 21 | = | Malignant Prostate Neoplasm | 39.5 | 41.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 34815
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 1375
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10513
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580286 |
| 22 | = | Malignant Vulvar Neoplasm | 34.7 | 38.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 1555
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 54
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10135
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580287 |
| 23 | = | Malignant Esophageal Neoplasm | 31.8 | 35.3 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 16274
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 518
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9196
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580288 |
| 24 | = | Malignant Kidney Neoplasm | 29.8 | 32.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 15215
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 453
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10639
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580289 |
| 25 | = | Malignant Liver Neoplasm | 29.7 | 29.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 30532
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 906
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9511
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580290 |
| 26 | = | Malignant Rectal Neoplasm | 28.7 | 26.5 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 13446
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 386
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9385
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580291 |
| 27 | = | Malignant Lip and Oral Cavity Neoplasm | 27.5 | 23.5 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 5424
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 149
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 8881
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580292 |
| 28 | = | Skin Carcinoma | 23.3 | 20.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 5462
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 127
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9889
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580293 |
| 29 | = | Malignant Lung Neoplasm | 20.5 | 17.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 128762
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 2644
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9763
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580294 |
| 30 | = | Malignant Bladder Neoplasm | 19.9 | 14.7 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 17396
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 346
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10702
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580295 |
| 31 | = | Malignant Pancreatic Neoplasm | 17.6 | 11.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 51327
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 904
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9637
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580296 |
| 32 | = | Malignant Laryngeal Neoplasm | 16.1 | 8.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 4095
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 66
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9700
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580297 |
| 33 | = | Cutaneous Melanoma | 9 | 5.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 8671
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 78
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9826
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580298 |
| 34 | = | Malignant Gallbladder Neoplasm | 7.3 | 2.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 4402
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 32
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9574
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580299 |
| 35 | = | Malignant Colon Neoplasm | 5.5 | 0 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 40801
- formula
- active_trials / (mortality_count / 1000) (same geography, year, sex, source family; deaths ≥ 100)
- thresholds
- minDeaths
- 100
- minActivity
- 1
- activeTrials
- 225
- burdenSourceId
- CI-SOURCE-00000011
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9322
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580300 |